TP53 and neoplasm: Towards evaluating the therapeutic potential of the pH-triggered transfection of p53 and KillerRed, we subsequently studied tumour growth suppression after a single delivery with the bPEI25K/DNA-complex or DNA-complex after tail vein administration.